Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

Rob Adams

Executive Partner

Andrew Baum

Vice President, Treasury and Capital Management

Ali Byrd

Investor Advisory Council Member

Marco A. Casas

Senior Investment Principal, Basecamp Fund

Helen Chen

CEO Services Analyst

Cainon Coates

Managing Partner

Michael Collins

Co-Founder, CEO and Board Chairman

Mason Hale

Senior Associate, Chestnut Street and Triphammer

Michael Madden

Co-Founder and Investment Professionals

Tom Meyer

Managing Partner, Nassau Street

Wayne Moore

Partner

David Muson

CFO

Saad Shaheen

Director

Justin Strausbaugh

Managing Partner, Lakeshore

Edward Tsai

Managing Partner

Brittney Wade

Senior Associate, Seed Fund and Doctors Innovate Fund

Drew Wandzilak

Senior Associate, Green D and Yard and Strategic Tech Fund

Sarah Worden

Venture Scout

Michael Yuann

Director of Investment Operations

Past deals in Health Care

Salvo Health

Seed Round in 2025
Salvo Health is a virtual health clinic that specializes in treating chronic gut conditions. The company enhances access to specialized healthcare for individuals suffering from these conditions through its app-based platform. Salvo Health utilizes a proprietary approach known as Whole Self Science, which considers various health factors beyond just gastrointestinal issues. This comprehensive model allows healthcare providers to identify the root causes of chronic illnesses and develop personalized, ongoing treatment strategies tailored to each patient's needs. By focusing on individualized care, Salvo Health aims to improve the overall well-being of those with chronic gut-related illnesses.

The Helper Bees

Series C in 2025
The Helper Bees, Inc. is a company based in Austin, Texas, that operates a platform connecting seniors with local caregivers for a variety of home care services across the United States. Founded in 2015, the platform allows seniors to find and hire helpers for tasks such as light housekeeping, grocery shopping, transportation to appointments, companionship, and specialized care for conditions like Alzheimer’s, dementia, and diabetes. The Helper Bees aims to enhance the home care experience by collaborating with major insurance carriers, utilizing digital solutions and machine learning to streamline care options and improve claim processing. This focus on technology and direct access to caregivers helps families navigate the complexities of home care, ensuring that seniors receive the support they need.

MetaSight Diagnostics

Series A in 2024
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).

Lōvu

Pre Seed Round in 2024
Lōvu Health is a digital health company specializing in maternal care. It provides a platform that supports mothers and babies from conception through to postpartum, using AI to deliver real-time analytics and evidence-based insights. The platform monitors vital signs like fetal heart rate and blood pressure, offers personalized recommendations, and sends action-oriented alerts, empowering users with reliable information and expert knowledge.

Bionic Health

Seed Round in 2024
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.

Syntra

Pre Seed Round in 2024
Syntra develops an EHR platform that streamlines billing, records, and follow-ups, helping doctors automate tasks.

Clarium Health

Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

Grayce

Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized support for families and employees managing the care of aging adults and children. Established in 2019, Grayce offers a comprehensive range of services, including assistance with insurance, finances, legal plans, medical care, home care, housing, and daily needs. The company emphasizes individualized guidance, ensuring that each member receives dedicated support from a social worker who helps manage their overall care. This includes planning, resource identification, care coordination, and advocacy, empowering family caregivers to effectively navigate the complexities of caring for their loved ones.

caVos biotherapeutics

Seed Round in 2024
An emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms

Bionaut Labs

Series B in 2024
Bionaut Labs, Inc. is a biotechnology company based in Palo Alto, California, founded in 2016. The company specializes in developing a novel intra-tissue navigation platform utilizing Bionaut nano/micro robots that operate within the body. This innovative technology enables precise anatomical targeting for the treatment of central nervous system disorders, offering a new approach to precision medicine. By employing remote-controlled micro-robots, Bionaut Labs enhances the development of therapeutics, making advanced technologies like gene therapy and CRISPR-Cas9 feasible in challenging clinical scenarios. The Bionaut platform allows medical professionals to access any anatomic location within the body, facilitating the automation of complex procedures while eliminating the need for external incisions, thereby improving patient outcomes for those with limited treatment options.

Clarity Pediatrics

Seed Round in 2024
Clarity Pediatrics is focused on transforming pediatric chronic care, particularly for children diagnosed with Attention-deficit/hyperactivity disorder (ADHD), which affects nearly 10% of American children. The company has developed a virtual pediatric ADHD clinic that utilizes a tech-enabled platform to deliver high-quality care to families. This platform includes features such as video conferencing, secure messaging, and electronic health records, allowing for accessible and efficient communication. Clarity Pediatrics aims to provide trusted care that is backed by scientific research, with the goal of achieving exceptional health outcomes that can significantly improve a child's developmental trajectory. By leveraging technology, the clinic seeks to reach a broader market of families, irrespective of their location or insurance status, ensuring that children receive the necessary support and resources.

Pi Health

Series A in 2024
Pi Health is a technology company specializing in streamlining oncology clinical trials. It offers a global, secure, and compliant platform that integrates various systems, enabling life sciences companies to identify suitable trial sites, manage them efficiently, and accelerate the development of lifesaving medicines. This, in turn, enhances patient access to cancer care and research, particularly for diverse populations.

Nest Health

Seed Round in 2024
Nest Health is a family healthcare platform that provides a range of medical services aimed at reducing the stress associated with traditional healthcare arrangements. The company specializes in delivering in-home and virtual visits for patients of all ages, including newborns, children, teens, and adults. Their offerings encompass preventive care, sick visits, behavioral health support, nutrition guidance, and chronic disease management. By enabling patients to receive care in the comfort of their homes, Nest Health seeks to enhance accessibility and convenience in healthcare delivery.

Oula Health

Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

BetterYou

Series A in 2023
BetterYou is a digital wellness platform that empowers individuals and organizations to make informed health and wellness decisions. By analyzing daily data from users' devices, the platform offers insights into how individuals allocate their time versus what they value most. BetterYou helps users define their personal goals for “time better spent” and supports them in achieving those objectives. Additionally, the platform provides organizations with population-level insights that can lead to improved employee wellness and potential health care savings. By focusing on the interconnected aspects of physical, mental, social, and educational wellness, BetterYou facilitates healthier habits and enhances overall well-being for both individuals and businesses.

Clarium Health

Seed Round in 2023
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

Taro Health

Seed Round in 2023
Taro Health is a health insurance company that aims to provide affordable, relationship-based healthcare services to Americans. The company focuses on enhancing the interactions between doctors and patients, striving to reduce barriers in communication and care. By investing in initiatives that foster meaningful connections between healthcare providers and patients, Taro Health enables individuals to receive personalized and holistic treatments tailored to their specific healthcare needs.

Upside Health

Seed Round in 2023
Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its mobile application, Ouchie. This application provides targeted educational content and rewards for achieving functional milestones, fostering a support system for patients. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to enhance care quality while minimizing the burden on healthcare providers. By empowering patients with data and social support, Upside Health aims to improve outcomes for chronic pain sufferers and create revenue-generating opportunities for healthcare practices.

Pair Eyewear

Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.

AlliConnect

Seed Round in 2023
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

DropStat

Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.

Bionic Health

Seed Round in 2023
Bionic Health is a digital healthcare company focused on providing preventative health services, particularly for individuals experiencing chronic pain. The company has developed a platform that utilizes frequent diagnostics and machine learning to create personalized treatment plans. This approach emphasizes slowing down the aging process and offers patients tailored insights derived from ongoing assessments. By implementing an iterative journey, Bionic Health enables users to identify their unique health needs and make impactful lifestyle changes over time. Additionally, patients benefit from closely monitored preventative care throughout the year, enhancing their overall well-being.

Oula Health

Series A in 2023
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.

Brave Health

Series C in 2022
Brave Health operates a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management, which encompasses medication-assisted treatment. This telehealth approach allows patients to receive comprehensive care for various conditions related to mental health and substance use disorders, facilitating greater access to necessary treatment.

Koala Health

Series A in 2022
Koala Health is a Boston-based company founded in 2021 that specializes in providing medications and health products for pets. The company simplifies pet care by verifying and fetching prescriptions from veterinarians, sorting and packaging medications by date and time, and offering free delivery and refills. By focusing on vet-approved medications and supplements, Koala Health aims to enhance the quality of life for pets and support pet owners in managing their pets' health needs effectively.

Nanopath

Series A in 2022
Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.

Sesame

Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Boulder Care

Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.

The Helper Bees

Series B in 2022
The Helper Bees, Inc. is a company based in Austin, Texas, that operates a platform connecting seniors with local caregivers for a variety of home care services across the United States. Founded in 2015, the platform allows seniors to find and hire helpers for tasks such as light housekeeping, grocery shopping, transportation to appointments, companionship, and specialized care for conditions like Alzheimer’s, dementia, and diabetes. The Helper Bees aims to enhance the home care experience by collaborating with major insurance carriers, utilizing digital solutions and machine learning to streamline care options and improve claim processing. This focus on technology and direct access to caregivers helps families navigate the complexities of home care, ensuring that seniors receive the support they need.

AlliConnect

Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

AlliConnect

Seed Round in 2022
Alli Connect is a breakthrough B2B software for patient provider matching in mental health care. Our powerful technology proactively promotes wellness, improves patient clinical outcomes and eliminates the trial and error currently utilized in seeking treatment. Alli Connect’s platform is customized to each individual customer organization to drive high engagement and quantify effectiveness in access to care. The data gathered by the Alli Connect technology provides the ability to make data driven decision in mental health for Value Based Care. Our unique approach and technology has been validated by more than 5 years of data, increasing success in access to mental health care from 19% to 88%! Alli Connect was founded and is led by Colleen Hilton, a 2x founder and licensed mental health provider; with the unique industry knowledge required to successfully tackle the healthcare business market.

Gordy Health

Convertible Note in 2021
Gordy Health is a virtual care provider specializing in blood pressure management to reduce the risk of serious health complications such as heart attacks, strokes, and kidney failure. Founded in 2021 and headquartered in Pasadena, California, the company offers a healthcare platform that allows users to manage their blood pressure from home. This platform provides direct access to heart specialists, facilitates easy scheduling of virtual appointments, and includes features such as real-time diagnostics, prescription delivery, and continuous monitoring and medication adjustments. By focusing on proactive management of high blood pressure, Gordy Health aims to help individuals lead healthier lives and extend their longevity.

Evernow

Convertible Note in 2021
Evernow is a provider of women's health care services focused on supporting women before, during, and after menopause. The company offers an online teleconsultation platform that connects users with specialized doctors and provides access to science-backed information and treatments. Through this platform, Evernow facilitates conversations about effective care for managing changing hormones, empowering women to lead longer and healthier lives.

BetterYou

Venture Round in 2021
BetterYou is a digital wellness platform that empowers individuals and organizations to make informed health and wellness decisions. By analyzing daily data from users' devices, the platform offers insights into how individuals allocate their time versus what they value most. BetterYou helps users define their personal goals for “time better spent” and supports them in achieving those objectives. Additionally, the platform provides organizations with population-level insights that can lead to improved employee wellness and potential health care savings. By focusing on the interconnected aspects of physical, mental, social, and educational wellness, BetterYou facilitates healthier habits and enhances overall well-being for both individuals and businesses.

Leo Cancer Care

Series B in 2021
Leo Cancer Care is focused on revolutionizing cancer radiation therapy by offering a treatment system designed to enhance patient experience and outcomes. Founded in Australia, the company leverages global research that highlights the benefits of upright patient positioning during treatment. This innovative approach shifts the traditional paradigm of machine rotation to patient rotation, allowing for a more controlled and efficient therapy process. The system integrates advanced 3D imaging and precise radiation beam management, ensuring that the appropriate amount of energy is delivered to targeted tissues. By streamlining cancer treatment and connecting patients to centralized care centers, Leo Cancer Care aims to reduce both the physical discomfort and costs typically associated with chemotherapy and radiation therapy, ultimately putting patients in control of their treatment journey.

Asto CT

Series B in 2021
Asto CT LLC specializes in developing advanced X-ray computed tomography (CT) systems aimed at enhancing equine healthcare. Founded in 2015 and based in Madison, Wisconsin, the company focuses on preventing fractures and improving the overall well-being of thoroughbreds, show horses, recreational horses, and older equines. Asto CT's technology enhances fracture risk detection, facilitates the diagnosis of lameness, and aids in the management of dental and sinus conditions. Their flagship product, Equina, delivers rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, ensuring a safer and more comfortable experience for the animals. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is committed to providing high-quality diagnostic imaging that supports veterinarians in delivering effective treatments.

Future Family

Series A in 2021
Future Family, Inc. is a subscription-based fertility company founded in 2016 and headquartered in San Francisco, California. It provides comprehensive healthcare solutions for individuals and couples navigating fertility challenges, offering plans that cover all associated costs. The company's services include personalized fertility planning, clinic matching, and a dedicated nurse concierge, ensuring 24/7 access to a care team. Future Family specializes in on-demand medical support for procedures such as in vitro fertilization (IVF) and egg freezing, and it features a digital health platform for managing fertility care. By combining financial assistance with expert guidance, Future Family aims to deliver a stress-free fertility experience for its clients.

Intus Care

Seed Round in 2021
Intus Care, Inc. is a healthcare analytics platform focused on improving patient care and reducing hospitalizations for vulnerable and complex patients. Founded in 2018 and based in North Providence, Rhode Island, the company connects home care providers to patients through an application that tracks provider efficiency via electronic visit verification. Utilizing machine learning, the platform predicts hospital readmissions and identifies patients at high risk for hospitalizations. It also facilitates automatic patient risk grouping, enables care coordination teams to receive notifications about changes in patient health status, and supports the development of data-driven interventions and care plans. By synthesizing financial, clinical, and administrative data, Intus Care helps organizations such as nursing homes, PACE programs, and home care agencies visualize healthcare trends, ultimately aiming to deliver cost-effective healthcare solutions.

PulseData AI

Series A in 2021
PulseData AI, established in 2015 and headquartered in New York, specializes in healthcare technology. It develops machine learning software that helps healthcare providers identify patients at high risk of adverse, preventable medical outcomes. The company's platform analyzes vast amounts of patient data to predict health trends, enabling care management teams to deliver timely, targeted interventions and improve overall patient outcomes.

Grayce

Seed Round in 2020
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized support for families and employees managing the care of aging adults and children. Established in 2019, Grayce offers a comprehensive range of services, including assistance with insurance, finances, legal plans, medical care, home care, housing, and daily needs. The company emphasizes individualized guidance, ensuring that each member receives dedicated support from a social worker who helps manage their overall care. This includes planning, resource identification, care coordination, and advocacy, empowering family caregivers to effectively navigate the complexities of caring for their loved ones.

Matchwell

Venture Round in 2020
Matchwell LLC is an online marketplace that connects healthcare professionals, such as nurses and therapists, with healthcare facilities seeking staff. Founded in 2017 and headquartered in Durham, North Carolina, Matchwell allows clinicians to join preferred facility pools, view available shifts, and communicate directly with hiring managers. The platform caters to both short-term and long-term employment needs, promoting flexibility in work arrangements. By leveraging technology and artificial intelligence, Matchwell aims to enhance workforce management for healthcare organizations while providing transparency and direct access to job opportunities for clinicians. With over 50,000 clinicians and 1,000 healthcare sites under contract, Matchwell is actively redefining the dynamics of a flexible healthcare workforce.

Emme

Seed Round in 2019
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on enhancing women's health through innovative solutions. The company has developed the Emme Smart Case and a corresponding mobile application, which together help women manage their birth control more effectively. The smart case employs multi-sensor technology to track when birth control pills are taken, alleviating the stress of remembering to take them and alerting users when back-up contraception is necessary. Additionally, the app provides a comprehensive health overview by allowing users to track their menstrual cycles, mood, and side effects. Founded in 2000, Emme aims to modernize the birth control experience for women, aligning it with contemporary technological advancements.

She's Well

Seed Round in 2019
She's Well is a fertility management service that utilizes a subscription model to assist individuals and couples in starting families at their own pace. The company partners with leading fertility centers to provide financial plans for various services, including fertility testing, IVF, egg freezing, and sperm freezing. By adopting an on-demand concierge care approach, She's Well aims to simplify the often complex and isolating fertility journey. With one in six couples facing challenges in conception and a growing trend of delayed childbirth, She’s Well addresses a significant gap in infertility services, which currently reach only a small percentage of those in need. Typical costs for treatments like IVF can be prohibitively high, often ranging from $12,000 to $20,000, with additional expenses for genetic testing. She's Well seeks to make fertility care more affordable and accessible, promoting a future where family planning is not constrained by biological timelines and where comprehensive care options are available to all who wish to conceive.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Careswitch

Venture Round in 2019
Careswitch is transforming the home care industry by providing a comprehensive software platform designed to enhance operational efficiency for home care companies. This platform streamlines essential functions such as care planning, scheduling, documentation, and payroll, reducing the manual workload and allowing caregivers to concentrate on delivering quality care. Additionally, it includes a unique carer app that simplifies caregiving tasks and minimizes errors. By facilitating features like visit certification, billing, and invoicing, Careswitch enables its clients to expand their teams while maintaining compliance with industry regulations, ultimately improving the overall wellbeing of caregivers and those they serve.

E25Bio

Seed Round in 2019
E25Bio Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing rapid diagnostic tests for epidemic fever viruses, including dengue, chikungunya, and Zika. Founded in 2018, the company specializes in paper-based diagnostic systems that enable swift detection of viral antigens produced during infections. Its innovative platform allows for real-time data reporting through a mobile application, which captures results along with information on test timing and location. This approach aims to facilitate epidemiologic predictions and disease mapping, ultimately assisting governments and health organizations in managing outbreaks effectively and preventing public health crises. E25Bio's solutions are designed to provide affordable and timely diagnostics at the point of care.

Brave Care

Seed Round in 2019
Brave Care, Inc. specializes in urgent pediatric health care services, treating a wide range of conditions, including allergies, asthma, cough, ear pain, eye issues, fever, minor fractures, and rashes. The company also offers pediatric-specific laboratory services, on-site x-ray, and light sedation for certain procedures. Founded in 2019 and based in Portland, Oregon, Brave Care operates clinics exclusively designed for children in Oregon and Texas. In addition to in-person care, the BraveCare.com website and mobile app provide nationwide pediatric advice to assist parents in supporting their children's health and development.

Careswitch

Seed Round in 2019
Careswitch is transforming the home care industry by providing a comprehensive software platform designed to enhance operational efficiency for home care companies. This platform streamlines essential functions such as care planning, scheduling, documentation, and payroll, reducing the manual workload and allowing caregivers to concentrate on delivering quality care. Additionally, it includes a unique carer app that simplifies caregiving tasks and minimizes errors. By facilitating features like visit certification, billing, and invoicing, Careswitch enables its clients to expand their teams while maintaining compliance with industry regulations, ultimately improving the overall wellbeing of caregivers and those they serve.

Sesame

Series A in 2019
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Mahmee

Seed Round in 2019
Mahmee is an integrated care delivery platform focused on improving maternal and infant health. The company aims to address the critical gaps in the U.S. healthcare system, which faces high maternity costs and mortality rates, particularly among Black mothers and infants. By building a digital infrastructure that connects patients, independent health professionals, and healthcare organizations, Mahmee enhances access to comprehensive prenatal and postpartum care. Its platform includes a care management system that links health records for mothers and babies, flags clinical risks, and facilitates collaboration among maternity and infant care practitioners. Additionally, Mahmee’s marketplace allows new and expecting parents to discover care providers and access services both in-person and virtually, thereby supporting better health outcomes for families.

HENRY The Dentist

Series A in 2019
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Apprentice Health

Seed Round in 2018
Apprentice Health is a predictive analytics firm focused on enhancing the efficiency of healthcare systems through its comprehensive operations platform. Based in Boston, Massachusetts, the company aims to facilitate the transition to value-based care by identifying inefficiencies in workflows within clinics and hospitals. Its platform provides actionable recommendations for improving scheduling, staffing, and facility utilization. By addressing these areas, Apprentice Health helps healthcare providers increase patient access, enhance the patient experience, and alleviate clinical staff burnout. The firm was founded by Rajiv Sivendran and Artur Menzeleev, emphasizing a commitment to higher patient and staff satisfaction while also reducing operational costs.

Vital Plan

Venture Round in 2018
Vital Plan, Inc. specializes in producing natural supplements aimed at addressing various health conditions, including cardiovascular health, digestive issues, immune support, and stress management. Founded in 2008 and headquartered in Cary, North Carolina, the company aims to enhance transparency and credibility within the natural products industry, which has often faced criticism for misleading labeling and poor-quality ingredients. In addition to its range of supplements, Vital Plan offers guided educational wellness courses, health coaching, and physician-formulated supplement protocols to empower individuals on their health journeys. The company provides its products online, making them accessible to a broader audience seeking to improve their overall well-being.

Farcast

Series C in 2018
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with a lab in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the tumor microenvironment using fresh, unmodified human tumor fragments and autologous blood samples, enabling oncologists and drug developers to test individual tumors and predict patient response to treatments with higher accuracy. Farcast's mission is to illuminate personalized treatment paths for cancer patients by providing precise, patient-specific data.

Heal

Series C in 2018
Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.

Honor

Series C in 2018
Honor is a leading senior care network and technology platform that focuses on enhancing the quality of life for older adults and their families. Founded in 2014 by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg in San Francisco, California, Honor has established itself as a pioneer in the home care industry. The company offers expert in-home care services for seniors, leveraging an integrated system of third-party care providers. By combining scalable workforce management with personalized care, Honor enables older adults to live safely and comfortably in their own homes. In 2021, Honor expanded its reach by acquiring Home Instead, enhancing its capabilities through a global network and a relationship-based care model. This strategic move positions Honor to address the evolving needs of aging adults and professional caregivers worldwide.

Emme

Seed Round in 2018
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on enhancing women's health through innovative solutions. The company has developed the Emme Smart Case and a corresponding mobile application, which together help women manage their birth control more effectively. The smart case employs multi-sensor technology to track when birth control pills are taken, alleviating the stress of remembering to take them and alerting users when back-up contraception is necessary. Additionally, the app provides a comprehensive health overview by allowing users to track their menstrual cycles, mood, and side effects. Founded in 2000, Emme aims to modernize the birth control experience for women, aligning it with contemporary technological advancements.

HENRY The Dentist

Seed Round in 2017
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.

Compass Therapeutics

Series A in 2016
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.

CareLinx

Venture Round in 2016
CareLinx, established in 2011 and based in San Bruno, California, operates a nationwide online platform that connects families with licensed caregivers. The company's innovative model streamlines caregiving management, enabling families to hire, schedule, track time, coordinate care, and process payroll online. This approach reduces costs by up to 50% compared to traditional brick-and-mortar agencies, while caregivers earn higher wages. CareLinx's platform also supports clinical teams by providing tech-enabled caregivers who act as their extended eyes, ears, and hands in patients' homes, enhancing health outcomes.

Compass Therapeutics

Series A in 2015
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.

CareLinx

Series A in 2015
CareLinx, established in 2011 and based in San Bruno, California, operates a nationwide online platform that connects families with licensed caregivers. The company's innovative model streamlines caregiving management, enabling families to hire, schedule, track time, coordinate care, and process payroll online. This approach reduces costs by up to 50% compared to traditional brick-and-mortar agencies, while caregivers earn higher wages. CareLinx's platform also supports clinical teams by providing tech-enabled caregivers who act as their extended eyes, ears, and hands in patients' homes, enhancing health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.